Madrigal Pharmaceuticals, Inc. MDGL Total Current Assets
Total Current Assets at other companies
Other financials
Where this comes from
Reported directly by Madrigal Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AssetsCurrent.
The official record: Madrigal Pharmaceuticals, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Madrigal Pharmaceuticals, Inc.'s total current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Madrigal Pharmaceuticals, Inc.'s total current assets?
- Madrigal Pharmaceuticals, Inc. (MDGL) reported total current assets of $1.18B in Q1 2026.
- How has Madrigal Pharmaceuticals, Inc.'s total current assets changed year-over-year?
- Madrigal Pharmaceuticals, Inc.'s total current assets increased by 19.7% year-over-year, from $987.98M to $1.18B.
- What is the long-term trend for Madrigal Pharmaceuticals, Inc.'s total current assets?
- Over 5 years (2020 to 2025), Madrigal Pharmaceuticals, Inc.'s total current assets has grown at a 34.3% compound annual growth rate (CAGR), from $285.16M to $1.25B.
- What does total current assets mean?
- The sum of all assets that the company expects to turn into cash or use up within one year.
- How do you interpret total current assets?
- An increase generally indicates a stronger short-term financial position, while a decrease may signal liquidity pressure.
- How does total current assets compare across companies?
- Benchmark for assessing short-term solvency across the biopharmaceutical industry.